0001566028-13-000030.txt : 20131008
0001566028-13-000030.hdr.sgml : 20131008
20131008171840
ACCESSION NUMBER: 0001566028-13-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131004
FILED AS OF DATE: 20131008
DATE AS OF CHANGE: 20131008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC
CENTRAL INDEX KEY: 0000887497
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112638720
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 369 BAYVIEW AVENUE
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
BUSINESS PHONE: 5167898228
MAIL ADDRESS:
STREET 1: 369 BAYVIEW AVE.
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDWYN MARTIN M
CENTRAL INDEX KEY: 0001186837
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20424
FILM NUMBER: 131141949
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-10-04
0000887497
HI TECH PHARMACAL CO INC
HITK
0001186837
GOLDWYN MARTIN M
C/O TASHLIK KREUTZER GOLDWYN & CRANDELL
40 CUTTERMILL ROAD
GREAT NECK
NY
11021
1
0
0
0
Common Stock
2013-10-04
4
M
0
1500
24.95
A
1500
D
Common Stock
2013-10-04
4
S
0
1500
43.10
D
0
D
Stock Option (Right to Buy)
24.95
2013-10-04
4
M
0
1500
0
D
2006-11-08
2015-11-08
Common Stock
1500
7875
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.08 to $43.16, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
Other than the option to acquire an additional 9,375 shares of the Company's stock reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 75,400 shares of the Company's stock (for options to acquire an aggregate of 84,775 shares). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.
Martin M. Goldwyn
2013-10-08